has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.Online First from The Oncologist
- Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain
- When Cancer Hits the Oncologist's Home
- Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A…
- A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases
- Single‐Center Experience with Ifosfamide Monotherapy as Second‐Line Treatment of Recurrent/Metastatic Osteosarcoma
Clinical Trials Results from The Oncologist
- A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer [CLINICAL TRIAL RESULTS]
- A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN [CLINICAL TRIAL RESULTS]
- Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study [CLINICAL TRIAL RESULTS]
- Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non-Small Cell Lung Cancer [CLINICAL TRIAL RESULTS]